Literature DB >> 28235898

GABAergic Neurons of the Central Amygdala Promote Cataplexy.

Carrie E Mahoney1, Lindsay J Agostinelli1, Jessica N K Brooks1, Bradford B Lowell2, Thomas E Scammell3.   

Abstract

Narcolepsy is characterized by chronic sleepiness and cataplexy-sudden muscle paralysis triggered by strong, positive emotions. This condition is caused by a lack of orexin (hypocretin) signaling, but little is known about the neural mechanisms that mediate cataplexy. The amygdala regulates responses to rewarding stimuli and contains neurons active during cataplexy. In addition, lesions of the amygdala reduce cataplexy. Because GABAergic neurons of the central nucleus of the amygdala (CeA) target brainstem regions known to regulate muscle tone, we hypothesized that these cells promote emotion-triggered cataplexy. We injected adeno-associated viral vectors coding for Cre-dependent DREADDs or a control vector into the CeA of orexin knock-out mice crossed with vGAT-Cre mice, resulting in selective expression of the excitatory hM3 receptor or the inhibitory hM4 receptor in GABAergic neurons of the CeA. We measured sleep/wake behavior and cataplexy after injection of saline or the hM3/hM4 ligand clozapine-N-oxide (CNO) under baseline conditions and under conditions that should elicit positive emotions. In mice expressing hM3, CNO approximately doubled the amount of cataplexy in the first 3 h after dosing under baseline conditions. Rewarding stimuli (chocolate or running wheels) also increased cataplexy, but CNO produced no further increase. In mice expressing hM4, CNO reduced cataplexy in the presence of chocolate or running wheels. These results demonstrate that GABAergic neurons of the CeA are sufficient and necessary for the production of cataplexy in mice, and they likely are a key part of the mechanism through which positive emotions trigger cataplexy.SIGNIFICANCE STATEMENT Cataplexy is one of the major symptoms of narcolepsy, but little is known about how strong, positive emotions trigger these episodes of muscle paralysis. Prior research shows that amygdala neurons are active during cataplexy and cataplexy is reduced by lesions of the amygdala. We found that cataplexy is substantially increased by selective activation of GABAergic neurons in the central nucleus of the amygdala (CeA). We also demonstrate that inhibition of these neurons reduces reward-promoted cataplexy. These results build upon prior work to establish the CeA as a crucial element in the neural mechanisms of cataplexy. These results demonstrate the importance of the CeA in regulating responses to rewarding stimuli, shedding light on the broader neurobiology of emotions and motor control.
Copyright © 2017 the authors 0270-6474/17/373995-12$15.00/0.

Entities:  

Keywords:  DREADDs; cataplexy; hypocretin; mouse; narcolepsy; orexin

Mesh:

Year:  2017        PMID: 28235898      PMCID: PMC5391681          DOI: 10.1523/JNEUROSCI.4065-15.2017

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  67 in total

1.  Amygdala response to happy faces as a function of extraversion.

Authors:  Turhan Canli; Heidi Sivers; Susan L Whitfield; Ian H Gotlib; John D E Gabrieli
Journal:  Science       Date:  2002-06-21       Impact factor: 47.728

2.  Increases in paradoxical sleep as a result of amygdaloid stimulation.

Authors:  C T Smith; D E Miskiman
Journal:  Physiol Behav       Date:  1975-07

3.  All-day performance variations in normal and narcoleptic subjects.

Authors:  R Godbout; J Montplaisir
Journal:  Sleep       Date:  1986       Impact factor: 5.849

4.  Orexin neurons suppress narcolepsy via 2 distinct efferent pathways.

Authors:  Emi Hasegawa; Masashi Yanagisawa; Takeshi Sakurai; Michihiro Mieda
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

5.  The rat ponto-medullary network responsible for paradoxical sleep onset and maintenance: a combined microinjection and functional neuroanatomical study.

Authors:  Romuald Boissard; Damien Gervasoni; Markus H Schmidt; Bruno Barbagli; Patrice Fort; Pierre-Hervé Luppi
Journal:  Eur J Neurosci       Date:  2002-11       Impact factor: 3.386

Review 6.  From circuits to behaviour in the amygdala.

Authors:  Patricia H Janak; Kay M Tye
Journal:  Nature       Date:  2015-01-15       Impact factor: 49.962

7.  Behavioral state instability in orexin knock-out mice.

Authors:  Takatoshi Mochizuki; Amanda Crocker; Sarah McCormack; Masashi Yanagisawa; Takeshi Sakurai; Thomas E Scammell
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

8.  GABAB agonism promotes sleep and reduces cataplexy in murine narcolepsy.

Authors:  Sarah Wurts Black; Stephen R Morairty; Tsui-Ming Chen; Andrew K Leung; Jonathan P Wisor; Akihiro Yamanaka; Thomas S Kilduff
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

9.  Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function.

Authors:  Sawako Tabuchi; Tomomi Tsunematsu; Sarah W Black; Makoto Tominaga; Megumi Maruyama; Kazuyo Takagi; Yasuhiko Minokoshi; Takeshi Sakurai; Thomas S Kilduff; Akihiro Yamanaka
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

Review 10.  Sleep circuitry and the hypnotic mechanism of GABAA drugs.

Authors:  Jun Lu; Mary Ann Greco
Journal:  J Clin Sleep Med       Date:  2006-04-15       Impact factor: 4.062

View more
  17 in total

Review 1.  Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.

Authors:  Steven T Szabo; Michael J Thorpy; Geert Mayer; John H Peever; Thomas S Kilduff
Journal:  Sleep Med Rev       Date:  2018-11-08       Impact factor: 11.609

2.  A Discrete Glycinergic Neuronal Population in the Ventromedial Medulla That Induces Muscle Atonia during REM Sleep and Cataplexy in Mice.

Authors:  Shuntaro Uchida; Shingo Soya; Yuki C Saito; Arisa Hirano; Keisuke Koga; Makoto Tsuda; Manabu Abe; Kenji Sakimura; Takeshi Sakurai
Journal:  J Neurosci       Date:  2020-12-28       Impact factor: 6.167

Review 3.  Cataplexy and Its Mimics: Clinical Recognition and Management.

Authors:  Sigrid Pillen; Fabio Pizza; Karlien Dhondt; Thomas E Scammell; Sebastiaan Overeem
Journal:  Curr Treat Options Neurol       Date:  2017-06       Impact factor: 3.598

4.  Basal forebrain subcortical projections.

Authors:  Lindsay J Agostinelli; Joel C Geerling; Thomas E Scammell
Journal:  Brain Struct Funct       Date:  2019-01-05       Impact factor: 3.270

5.  Regulation of dark period sleep by the Amygdala: A microinjection and optogenetics study.

Authors:  Laurie L Wellman; Gyorgy Lonart; Austin M Adkins; Larry D Sanford
Journal:  Brain Res       Date:  2022-02-04       Impact factor: 3.252

6.  BK channel properties correlate with neurobehavioral severity in three KCNMA1-linked channelopathy mouse models.

Authors:  Su Mi Park; Cooper E Roache; Philip H Iffland; Hans J Moldenhauer; Katia K Matychak; Amber E Plante; Abby G Lieberman; Peter B Crino; Andrea Meredith
Journal:  Elife       Date:  2022-07-12       Impact factor: 8.713

7.  Melanin-concentrating hormone neurons contribute to dysregulation of rapid eye movement sleep in narcolepsy.

Authors:  Fumito Naganuma; Sathyajit S Bandaru; Gianna Absi; Carrie E Mahoney; Thomas E Scammell; Ramalingam Vetrivelan
Journal:  Neurobiol Dis       Date:  2018-08-24       Impact factor: 5.996

8.  Dual orexin receptor antagonists increase sleep and cataplexy in wild type mice.

Authors:  Carrie E Mahoney; Takatoshi Mochizuki; Thomas E Scammell
Journal:  Sleep       Date:  2020-06-15       Impact factor: 5.849

9.  Neuroscience: A Distributed Neural Network Controls REM Sleep.

Authors:  John Peever; Patrick M Fuller
Journal:  Curr Biol       Date:  2016-01-11       Impact factor: 10.834

Review 10.  The neurobiological basis of narcolepsy.

Authors:  Carrie E Mahoney; Andrew Cogswell; Igor J Koralnik; Thomas E Scammell
Journal:  Nat Rev Neurosci       Date:  2019-02       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.